Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by CancerSlayeron Feb 02, 2023 2:41pm
303 Views
Post# 35262986

RE:RE:RE:excellent ! Excellent ! NEWS

RE:RE:RE:excellent ! Excellent ! NEWS

blackjack0 wrote: Very encouraging that they are sharing their data at this conference. I imagine there will be some more data included that we are expecting in February sometime. I hope they make it clear that this includes the first 12 grossly under treated patients as it very much affects our early data. It seems a little unusual that they are putting out data at this type of conference. Some of our more knowledgeable posters will probably inform us on this. Very upbeat news release!!

 

From what I understand....The interim data that TLT had submitted in the abstract application process will be the data that is presented.  The deadline for abstract submissions is generally months in advance of the conference date, so I don't believe they can add to whatever data/poster was already accepted by the AUA.  

Based on our stage of development & the volume of data to be presented, a poster presentation is probably to be expected imo (vs an extended podium presentation).  The moderated poster format is certainly a more hands-on/direct visual presentation that includes a brief 1 minute poster presentation followed by a 2 minute discussion period.  Having a moderator helps highlight important aspects of our research & he/she is there to facilitate discussion, Q&A, etc.  Looking forward to the explosion of exposure we should be getting in the months to come.  Good luck...

<< Previous
Bullboard Posts
Next >>